{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "ChangeTypes.html": {"id": "ChangeTypes.html", "text": "ChangeTypes", "displayed_text": "ChangeTypes"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Medicine_66": {"DOI": "10.1186/s13578-015-0003-4", "id": "Medicine_66", "News Finding": "We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.", "Paper Finding": "Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury.", "News Context": "I/R also increased the release of cytochrome c and down-regulated the phosphorylation of PI3K, Akt and GSK-3b in the aging rat hearts. We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts. Supply of NaHS not only increased PC-induced cardioprotection in the young hearts, but also lightened I/R induced-myocardial damage and significantly recovered the cardioprotective role of PC against I/R induced myocardial damage in the aging hearts.", "Paper Context": "PC did not change the above mentioned indexes in comparison with the I/R (Figures 3, 4, 5 and 6 ). Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury. H 2 S produced by CSE in cardiovascular system acted as a physiological cardiac function regulator, which protected the cardiac function in ischemic reperfusion or hypoxia .", "scores": "[3.0, 4.0, 3.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "news", "News URL": "http://www.technology.org/2015/03/22/a-novel-target-for-the-treatment-of-aging-cardiovascular-diseases/", "text": "<b>Reported finding:</b> We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.<br><b>Paper finding:</b> Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury.", "displayed_text": "<b>Reported finding:</b> We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.<br><b>Paper finding:</b> Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury."}, "Medicine_94": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_94", "News Finding": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.", "Paper Finding": "The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude.", "News Context": "They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding. The results showed that:\n\nAspirin use was associated with an 11% lower risk of cardiovascular events. Approximately 250 patients needed to be treated with aspirin for 5 years to prevent a single heart attack, stroke or cardiovascular death.", "Paper Context": "6 This study showed that when analysis was restricted to populations with observation-derived 10-year cardiovascular event rate estimates of 10% or more, aspirin use was associated with an absolute risk decrease of 0.51% (5% CI, 0.06%-0.3%) for the cardiovascular composite outcome, but an absolute risk increase of 0.64% (5% CI, 0.35%-0.7%) for major bleeding. The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude. Aspirin use was not associated with a reduction in cardiovascular mortality, and deaths due to bleeding were rare.", "scores": "[5.0, 4.0, 1.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2019/01/190122114950.htm", "text": "<b>Reported finding:</b> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.<br><b>Paper finding:</b> The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude.", "displayed_text": "<b>Reported finding:</b> They found that while it was associated with a lower risk of heart attacks and other cardiovascular events, it did lead to an increased risk of major bleeding.<br><b>Paper finding:</b> The current study demonstrates that the absolute risk reduction for cardiovascular events and absolute risk increase for major bleeding associated with aspirin use were of similar magnitude."}, "Medicine_30": {"DOI": "10.1001/jama.2018.20578", "id": "Medicine_30", "News Finding": "With a daily aspirin, 57 rather than 61 people per 10,000 would be expected to suffer a heart attack or stroke; at the same time, 23 rather than 16 people per 10,000 would experience severe bleeding, on average.", "Paper Finding": "In this meta-analysis of 13 trials enrolling 164 225 participants without cardiovascular disease, aspirin use was associated with reductions in the composite cardiovascular outcome consisting of cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke.", "News Context": "That underlines how important it is not to start doing this until you've chatted to your doctor about it. With a daily aspirin, 57 rather than 61 people per 10,000 would be expected to suffer a heart attack or stroke; at the same time, 23 rather than 16 people per 10,000 would experience severe bleeding, on average. \"This seriously questions whether people who have not previously had heart attacks or strokes should be taking aspirin with the aim of reducing future cardiovascular events,\" Zheng told Lisa Rapaport at Reuters.", "Paper Context": "Aspirin use was associated with increased risk of major bleeding (HR, In this meta-analysis of 13 trials enrolling 164 225 participants without cardiovascular disease, aspirin use was associated with reductions in the composite cardiovascular outcome consisting of cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke. However, aspirin use was associated with an increased risk of major bleeding, intracranial bleeding, and major gastrointestinal bleeding with comparable absolute risk estimates.", "scores": "[3.0, 2.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.5, "source": "news", "News URL": "http://ct.moreover.com/?a=38333931091&p=1pl&v=1&x=RFNXfRDC7W6ykWiKhqzpYQ", "text": "<b>Reported finding:</b> With a daily aspirin, 57 rather than 61 people per 10,000 would be expected to suffer a heart attack or stroke; at the same time, 23 rather than 16 people per 10,000 would experience severe bleeding, on average.<br><b>Paper finding:</b> In this meta-analysis of 13 trials enrolling 164 225 participants without cardiovascular disease, aspirin use was associated with reductions in the composite cardiovascular outcome consisting of cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke.", "displayed_text": "<b>Reported finding:</b> With a daily aspirin, 57 rather than 61 people per 10,000 would be expected to suffer a heart attack or stroke; at the same time, 23 rather than 16 people per 10,000 would experience severe bleeding, on average.<br><b>Paper finding:</b> In this meta-analysis of 13 trials enrolling 164 225 participants without cardiovascular disease, aspirin use was associated with reductions in the composite cardiovascular outcome consisting of cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}